New User? Click here to register

HR+/HER2- non-metastatic disease adjuvant management in 2022.

ABSTRACT

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Breast arterial calcifications on screening mammograms A biomarker of cardiovascular events
Asma ZIDI
IA and breast screening: New tools and paradigms.
Isabelle THOMASSIN NAGGARA
Oncoplastic surgery in the conservative treatment of breast cancer.
David ATTALAH
What are the update of DESTINY BREAST 12 in HER2 positive disease with brain metastatis ?
Hassan GHAZAL
oncologist, Dubai
Managing Treatment Side Effects and Quality of Life
Devan MOODLEY